Literature DB >> 26323234

Genitourinary syndrome of menopause and the use of laser therapy.

Juana Hutchinson-Colas1, Saya Segal2.   

Abstract

Genitourinary syndrome of menopause is a common condition that left untreated can progress and negatively affect quality of life and sexual function. Laser therapy has a therapeutic role for several gynecologic conditions and most recently has gained interest as a non-hormonal treatment for genitourinary syndrome of menopause (GSM). The laser is well tolerated and may increase thickness of the squamous epithelium and improve vascularity of the vagina. These morphological changes presumably alleviate symptoms of dryness, dyspareunia, and irritation. However, the duration of therapeutic effects and safety of repeated applications at this point is not clear. Further research is needed in the form of controlled studies of the laser and other non-hormonal GSM therapies. The objective of this paper is to review the existing literature describing laser therapy for GSM.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrophic vaginitis; Fractional CO(2) laser treatment; Genitourinary syndrome; Laser therapy; Postmenopausal symptoms; Vulvo vaginal atrophy

Mesh:

Year:  2015        PMID: 26323234     DOI: 10.1016/j.maturitas.2015.08.001

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  12 in total

1.  Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W?

Authors:  Eleni Pitsouni; Themos Grigoriadis; Matthew Falagas; Angeliki Tsiveleka; Stefano Salvatore; Stavros Athanasiou
Journal:  Lasers Med Sci       Date:  2017-08-02       Impact factor: 3.161

Review 2.  Laser Therapy for Genitourinary Syndrome of Menopause.

Authors:  Andrew Rabley; Tina O'Shea; Russell Terry; Sharon Byun; M Louis Moy
Journal:  Curr Urol Rep       Date:  2018-08-17       Impact factor: 3.092

3.  An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction.

Authors:  Rebecca G Rogers; Rachel N Pauls; Ranee Thakar; Melanie Morin; Annette Kuhn; Eckhard Petri; Brigitte Fatton; Kristene Whitmore; Sheryl A Kingsberg; Joseph Lee
Journal:  Int Urogynecol J       Date:  2018-03-26       Impact factor: 2.894

Review 4.  A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.

Authors:  Mariana S Sousa; Michelle Peate; Sherin Jarvis; Martha Hickey; Michael Friedlander
Journal:  Ther Adv Med Oncol       Date:  2017-01-31       Impact factor: 8.168

Review 5.  Missing documentation in breast cancer survivors: genitourinary syndrome of menopause.

Authors:  Elise D Cook; Elena I Iglehart; George Baum; Leslie L Schover; Lonzetta L Newman
Journal:  Menopause       Date:  2017-12       Impact factor: 2.953

6.  Prevalence and factors associated with sexual dysfunction among middle-aged women in a multi-ethnic country: A cross sectional study in Malaysia.

Authors:  Yin Yee Tey; Siew Mooi Ching; Mari Kannan Maharajan; Kai Wei Lee; Zhen Yee Chow; Pei Wen Chua; Chin Xuan Tan; Shi Nie Lim; Chun Han Tan; Hui Zhu Thew; Vasudevan Ramachandran; Fan Kee Hoo
Journal:  Malays Fam Physician       Date:  2022-03-17

7.  Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.

Authors:  A R Mothes; M Runnebaum; I B Runnebaum
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-27       Impact factor: 4.553

Review 8.  Vaginal rejuvenation using energy-based devices.

Authors:  Cheryl Karcher; Neil Sadick
Journal:  Int J Womens Dermatol       Date:  2016-06-21

Review 9.  Current trends and future perspectives in pelvic reconstructive surgery.

Authors:  Mélanie Aubé; Le Mai Tu
Journal:  Womens Health (Lond)       Date:  2018 Jan-Dec

Review 10.  Current treatment options for postmenopausal vaginal atrophy.

Authors:  Iuliia Naumova; Camil Castelo-Branco
Journal:  Int J Womens Health       Date:  2018-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.